NRT product innovation and development
Everything we do is built around four core pillars, which enable the effective development of NRT products to help stop smoking cravings:
- Innovation
- Regulation
- Quality
- Science
As a small and agile specialist company focusing on nicotine replacement therapy (NRT), we leverage these skills to crack the complexities around tobacco addiction and smoking cravings.
Effective development requires the careful balancing of a multitude of skill sets, which when brought together realise an amplification of the sum of the individual skills. At Ventus Medical, we have worked hard to identify and combine these key skills in the right environment, nurtured by a creative company culture.
The result of this has enabled us to develop and produce our first NRT inhalation product, ENHALE, which has been granted European approved as a medical device and is aimed at helping those bound by tobacco addiction to stop smoking cravings and reduce associated risks.
INNOVATION
We’re developing the first medicine and medical device of its kind to treat smoking cravings and support cessation. We bring innovation to every aspect of our work.
REGULATION
Our team consists of genuine, experienced experts on international standards, who ensure that all our work is conducted in compliance with ISO 13485: 2016.
QUALITY
We combine the safety of medicine with the function of electronic nicotine delivery systems, and rigorous quality testing assures our devices are safe and effective.
SCIENCE
Research and development are the core of our scientific work. We use an evidence-based approach to inform the methods adopted to stop smoking cravings via our products.